FDA approves weight loss drugs which suppress appetite by affecting one or more neurotransmitters in the brain which also control appetite and mood. Various appetite suppressants increase the secretion of dopamine, norepinepheine or serotonin or inhbit the reuptake of these neurotransmitters into the nerve cell.
The article cited AMA's "Global Weight Loss Drugs Market Study" explored CAGR of %. According to the report, Rapidly Growing Child Obesity is one of the primary growth factors for the market. Rising Number of Diseases Due to Over Weight
is also expected to contribute significantly to the Weight Loss Drugs market. Overall, Weight-reducing Aid
applications of Weight Loss Drugs, and the growing awareness of them, is what makes this segment of the industry important to its overall growth.
Furthermore, some recent industry insights like "On 18th June 2018, Jenny Craig, the global leader in the weight loss industry, has launched DNA testing into its complete weight loss strategies." is constantly making the industry dynamic.
The report provides an in-depth analysis and forecast about the industry covering the following key features: o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies o Analyses the Global Weight Loss Drugs market according to Type, Application, and regions o Analyzes the top 10 players in terms of market reach, business strategy, and business focus o Provides stakeholders insights and key drivers & trends of the market
**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.
Market Size Estimation In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Weight Loss Drugs market and other related sub-markets covered in the study.
o Key & emerging players in the market have been observed through secondary research. o The industrys supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes. o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation The overall Weight Loss Drugs market size is calculated using market estimation process, the Weight Loss Drugs market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Weight Loss Drugs market size has been validated using both top-down and bottom-up approaches.